• Info
  • Insider Trading

Insider Transactions Reported by 14 Insiders of Clarus Therapeutics Holdings, Inc.

Location
Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Clarus Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kimberly M. Murphy Director 07 Jun 2022
H.I.G. Ventures - Clarus, LLC 10%+ Owner 09 Sep 2021
FFI FUND LTD 10%+ Owner 17 Sep 2021
THOMAS MCNERNEY & PARTNERS LP 10%+ Owner 20 Apr 2022
Mark A. Prygocki Sr. Director 07 Jun 2022
Joseph Hernandez Director 07 Jun 2022
Elizabeth Cermak Director 07 Jun 2022
Steven A. Bourne Chief Administrative Officer 11 Dec 2021
Robert E. Dudley Chief Executive Officer, Director 12 Dec 2021
Alex Zisson Director, 10%+ Owner 09 Sep 2021
Richard D. Peterson Chief Financial Officer 11 Dec 2021
Frank Jaeger Chief Commercial Officer 11 Dec 2021
John Kenneth Amory Director 07 Jun 2022
CBC SPVI Ltd 10%+ Owner 09 Sep 2021

Recent Insider Transactions by Companies or Individuals for Clarus Therapeutics Holdings, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.